retatrutide clinical trial results 2024 Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 Lilly's triple agonist, retatrutide, demonstrated

Supporting muscle health while on GLP-1 medications Preventing muscle loss while using Ozempic and other GLP-1 medications involves a multifaceted approach that prioritizes nutrition, exercise, and supplementation

Reconstitution: 2.0 mL per 20 mg vial (~10.0 mg/mL) for accurate unit measurements

Retatrutides ability to engage all three receptors may explain its superior results in clinical trials

Compounded GLP-1 medications are not FDA-approved finished drug products and require evaluation by a licensed clinician before any prescription can be issued

Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound

Any GLP-1 medication might make you feel nauseous